Coronavirus: General Features and Current Approach

Year 2020, Volume: 3 Issue: S1, 14 - 23, 15.05.2020

Sevim Meşe Ali Ağaçfidan

Abstract

The virus, which was isolated from the pneumonia cases in Wuhan City in Hubei Province of China for the first time in December 2019 and determined to be from the Coronaviridae family, was called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Genetic analysis of SARS-CoV-2, originating from zoonotic like other coronaviruses, indicates that it has the same origin as bat coronavirus populations. Since there is usually limited contact between humans and bats, the transmission of the virus to humans is more likely to occur through another animal species that is more likely to be contacted. This intermediate host can be a pet, a wild animal or a domesticated wild animal, but has not yet been identified. In this article, structural and epidemiological features of coronaviruses are examined and current developments about SARS-CoV-2, which take over the world, are evaluated.

Keywords

Coronavirus, SARS-CoV-2, epidemiology ve morphological features

Coronavirus: Genel Özellikler ve Güncel Yaklaşım

Abstract

İlk defa Aralık 2019’da Çin’in Wuhan Şehrinde ortaya çıkan pnömoni vakalarından izole edilen ve Coronaviridae ailesinden olduğu belirlenen virus “severe acute respiratory syndrome coronavirus-2; SARS-CoV-2” olarak adlandırılmıştır. Diğer coronaviruslar gibi zoonotik kaynaklı olan SARS-CoV-2’nin genetik analizleri, yarasa coronavirus popülasyonları ile aynı kökene sahip olduğunu göstermektedir. İnsanlar ve yarasalar arasında genellikle sınırlı bir temas olduğundan, virusun insanlara bulaşmasının, insanlar ile temas olasılığı daha fazla olan başka bir hayvan türü yoluyla gerçekleşmesi daha olasıdır. Bu ara konak, evcil bir hayvan, vahşi bir hayvan veya evcilleştirilmiş bir vahşi hayvan olabilir, ancak henüz tanımlanmamıştır. Bu makalede coronavirusların yapısal ve epidemiyolojik özellikleri incelenerek tüm dünyayı etkisi altına alan SARS-CoV-2’ye dair güncel gelişmeler değerlendirilmiştir.

Keywords

Coronavirus, SARS-CoV-2, epidemiyoloji ve yapısal özellikler

References

• 1. Almeida JD and Tyrell DAJ. The Morphology of Three Previously Uncharacterized Human Respiratory Viruses that Grow in Organ Culture. J. Gen. Virol 1967;1:175-8.
• 2. Khan JS and McIntosh K. History and Recent Advances in Coronavirus Discovery. Pediatr Infect Dis J 2005;24:223–7.
• 3. Hamre D, Procknow JJ. A New Virus İsolated from the Human Respiratory Tract. Downloaded from ebm. sage. pubcom at Univ California San Diego on August 27,2015.
• 4. Cui J, Li F and Shi ZL. Origin and evolution of pathogenic coronaviruses. Nature Reviews/ Microbiology 2019;17:181-7.
• 5. Christopher J. Burrell, Colin R. Howard and Frederick A. Murphy, editors. Fenner and White’s Medical Virology. 5th Edition. Academic Press; 2017.
• 6. Stadler K, Masignani V, Eickmann M, Becker S et all. SARS — beginning to understand a new virus. SARS — beginning to understand a new virus. Nature Reviews Microbiology volume 1, pages209–218(2003). DOI: http://dx.doi. org/10.1016/B978-0-12-375156-0.00031-X.
• 7. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–23.
• 8. International Committee on Taxonomy of Viruses (ICTV). Taxonomic Information. https://talk. ictvonline.org/taxonomy/. Erişim: 02.02.2020.
• 9. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). Updated recommendations October 2004. https:// www.who.int/csr/resources/publications/WHO_ CDS_CSR_ARO_2004_1.pdf?ua=1. Erişim: 02.02.2020
• 10. Berry M, Gamieldien J and Fielding BC. Identification of New Respiratory Viruses in the New Millennium. Viruses 2015;7:996-1019. DOI:10.3390/v7030996.
• 11. WHO, Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/ emergencies/mers-cov/en/ Erişim: 02.02.2020
• 12. Qun Li, M.Med., Xuhua Guan and at all. Early Transmission Dynamics in Wuhan, China of Novel Coronavirus–Infected Pneumonia. The New England Journal of Medicine, 2020. DOI: 10.1056/NEJMoa2001316.
• 13. ECDC, Novel coronavirus. https://www.ecdc. europa.eu/en/novel-coronavirus-china. Erişim: 02.02.2020.
• 14. Riou J and Althaus LC. Pattern of early humanto-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020; 25(4): 2000058. doi: 10.2807/1560-7917.ES.2020.25.4.2000058.
• 15. Kwok OK, Thank A, Wei WIV et all. Epidemic Models of Contact Tracing: Systematic Review of Transmission Studies of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. Computational and Structural Biotechnology Journal 2019;17:186–194.
• 16. WHO, Novel Coronavirus (2019-nCoV) Situation Report – 33. Erişim: 02.02.2020. https://www. who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports/
• 17. World Health Organization Best Practices for the Naming of New Human Infectious Diseases May 2015. Erişim: 22.02.2019. https://apps.who.int/ iris/bitstream/handle/10665/163636/WHO_ HSE_FOS_15.1_eng.https://doi.org/10.1515/ cclm-2020-0285.
• 18. WHO, Origin of SARS-CoV-2 (26 March 2020). https://www.who.int/health-topics/coronavirus/ who-recommendations-to-reduce-risk-oftransmission-of-emerging-pathogens-fromanimals-to-humans-in-live-animal-markets. Erişim: 19.04.2020.
• 19. Di Wu, Tiantian Wu, Qun Liu, Zhicong Yang. The SARS-CoV-2 Outbreak: What We Know. DOI: https://doi.org/10.1016/j.ijid.2020.03.004.
• 20. Anfinrud P, Stadnytskyi V, Bax CE, Bax A. Visualizing speech-generated oral fluid droplets with laser light scattering. N Engl J Med. DOI: 10.1056/NEJMc2007800.
• 21. European Centre for Disease Prevention and Control (ECDC). Situation update worldwide, as of 19 April 2020. https://www.ecdc.europa.eu/en/ geographical-distribution-2019-ncov-cases. Erişim: 19.04.2020.
• 22. Chih-Cheng Lai, Tzu-Ping Shih, Wen-Chien Ko, Hung-JenTang et all. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 2020;55(3):105924.
• 23. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr. 2020;63(4):119-124. doi: 10.3345/ cep.2020.00493. Epub 2020 Apr 2.
• 24. Türkiye Cumhuriyeti Sağlık Bakanlığı COVID-19 Yeni Coronavirus Hastalığı. https://covid19bilgi. saglik.gov.tr/tr/ Erişim: 19.04.2020
• 25. WHO. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019nCoV in humans. https://www.who.int/ emergencies/diseases/novel-coronavirus-2019/ technical-guidance/laboratory-guidance Erişim: 19.04.2019
• 26. T.C Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 2019-nCoV Hastalığı Rehberi (Bilim Kurulu Çalışması). https://covid19bilgi.saglik.gov. tr/depo/rehberler/COVID-19_Rehberi. pdf?type=file Erişim: 19.04.2020
• 27. Lippi G, Simundica AM ve Plebania M. Potential Preanalytical and Analytical Vulnerabilities in the Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19). Clin Chem Lab Med 2020; aop. DOI:
• 28. Theel ES, Slev P, Wheeler S, Couturier MR, Wong JS, Kadkhoda K. The Role of Antibody Testing for SARS-CoV-2: Is There One? J. Clin. Microbiol. DOI:10.1128/JCM.00797-20.
• 29. CDC, Prevention and Treatment. Erişim: 19.04.2020 https://www.cdc.gov/coronavirus/ about/prevention.html
• 30. Tung Thanh Le, Zacharias Andreadakis, Arun Kumar, Raúl Gómez Román, Stig Tollefsen, Melanie Saville & Stephen Mayhew. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 09 April 2020. Erişim: 29.04.2020. https://www.nature.com/ articles/d41573-020-00073-5.